Mutations of WNK1 and WNK4 are considered to be related with pseudohypoaldosteronism type II (PHA II), an autosomal dominant disease featuring hypertension, hyperkalemia, hyperchloremia and metablic acidosis13, 14. Here, WNK1 is linked to Hypertension.